Back
Pharming Group NV Vs. Oracle Corp. Industry Stock Comparison
Sell
42
PHAR
Pharming Group NV
Last Price:
$17.49
Seasonality Move:
-2.42%
Sell
33
ORCL
Oracle Corp.
Last Price:
$198.40
Seasonality Move:
12.95%
Sell
42
Pharming Group NV (PHAR)
is a Sell
Is Pharming Group NV a Buy, Sell or Hold?
-
The current Pharming Group NV [PHAR] share price is $16.62. The Score for PHAR is 42, which is 16% below its historic median score of 50, and infers higher risk than normal.
-
PHAR is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
33
Oracle Corp. (ORCL)
is a Sell
Is Oracle Corp. a Buy, Sell or Hold?
-
The current Oracle Corp. [ORCL] share price is $191.97. The Score for ORCL is 33, which is 34% below its historic median score of 50, and infers higher risk than normal.
-
ORCL is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
PHAR Stock Price Chart
What is Pharming Group NV's stock price today?
-
The Pharming Group NV share price today is $16.62Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and PHAR is experiencing buying pressure, which is a positive indicator for future bullish movement.
ORCL Stock Price Chart
What is Oracle Corp.'s stock price today?
-
The Oracle Corp. share price today is $191.97Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and ORCL is experiencing slight buying pressure.
PHAR Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 3.1 | Buy |
| Relative Strength Index (14 RSI): | 51.04 | Buy |
| Chaikin Money Flow: | 7412 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (16.16 - 17.36) | Sell |
| Bollinger Bands (100): | (12.93 - 16.37) | Buy |
ORCL Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -13.05 | Sell |
| Relative Strength Index (14 RSI): | 39.43 | Sell |
| Chaikin Money Flow: | 7700855 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (190.85 - 218.91) | Sell |
| Bollinger Bands (100): | (213.99 - 288.93) | Sell |
PHAR Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 16.95 | Sell |
| 20-day SMA: | 16.88 | Sell |
| 50-day SMA: | 15.58 | Buy |
| 200-day SMA: | 12.13 | Buy |
| 8-day EMA: | 8.74 | Buy |
| 20-day EMA: | 4.28 | Buy |
| 50-day EMA: | 1.87 | Buy |
| 200-day EMA: | 0.49 | Buy |
ORCL Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 191.98 | Sell |
| 20-day SMA: | 201.13 | Sell |
| 50-day SMA: | 236.73 | Sell |
| 200-day SMA: | 213.56 | Sell |
| 8-day EMA: | 191.55 | Buy |
| 20-day EMA: | 203.18 | Sell |
| 50-day EMA: | 225.12 | Sell |
| 200-day EMA: | 220.12 | Sell |
Pharming Group NV Earnings Growth & PHAR Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.01 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.01 per share, and an increase next year of $0.07 per share.
Oracle Corp. Earnings Growth & ORCL Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.22 per share, an increase next quarter of $0.17 per share, an increase this year of $0.41 per share, and an increase next year of $1.34 per share.
Pharming Group NV Technical Analysis
| Dec 8 | Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 15 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 08 | 09 | 10 | 11 | 12 | 15 | 16 | 17 | 18 | 19 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Oracle Corp. Technical Analysis
| Dec 8 | Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 15 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 08 | 09 | 10 | 11 | 12 | 15 | 16 | 17 | 18 | 19 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||